Header image


Drug Reimbursement & Patient Assistance Programs

ANCO acknowledges the assistance of Lash Group Healthcare Consultants for their help in compiling this information. For general assistance information, also visit:

Association of Community Cancer Centers

CancerCare Co-Payment Assistance Foundation

Chronic Disease Fund

HealthWell Foundation

National Organization for Rare Disorders


Partnership for Prescription Assistance

Patient Advocate Foundation

Patient Services Incorporated



ANCO Corporate Member
Drug Reimbursement & Patient Assistance Programs
(click on the Corporate Member Name to view a summary and links
to their Drug Reimbursement & Patient Assisitance Programs)

Agendia • Alexion PharmaceuticalsAMAG PharmaceuticalsAMGEN
Astellas Oncology AstraZeneca
Bayer Healthcare Pharmaceuticals/Onyx Pharmaceuticals
Biodesix • Boehringer Ingelheim Pharmaceuticals • Bristol-Myers Squibb Oncology
Cardinal Health Specialty SolutionsCelgene • Daiichi Sankyo • Dendreon • Eisai
Foundation MedicineGenentech BioOnoclogyGenomic Health • Genoptix Medical Laboratory
Gilead Sciences • Helsinn Oncology • Incyte • Ipsen Biopharmaceuticals
Janssen Biotech • Lilly Oncology
MedivationMerck • NanoString • Novartis Oncology
Oncology Supply/International Oncology NetworkOnyx PharmaceuticalsPfizer Oncology 
Pharmacyclics • Sandoz Biopharmaceuticals • Sanofi OncologySeattle Genetics
Sargas Pharmaceutical Adherence & Compliance (SPAC) International
Takeda OncologyTeva Oncology

Alexion Pharmaceuticals
(888) 765-4747

Back to Top


AMAG Pharmaceuticals
AMAG Assist
(877) 411-2510, Opt 1, Opt 4;
FAX: (866) 470-5871;
9:00AM-5:00PM Eastern Time
In our ongoing commitment to providers and patients, AMAG Pharmaceuticals has established AMAG Assist, a comprehensive reimbursement support program. Our experienced AMAG Assist counselors can help with: insurance verifications, coding and billing support, claims tracking and appeals support, and alternative funding research. Furthermore, for patients who are uninsured and ahve not other source of drug coverate that can be identified, they may be eligible to participate in teh Patient Assistance Program for Feraheme. For more information, please visit www.feraheme.com.

MuGard Mucoadhesive Patient Reimbursement & Support Center (MPRSC)
(888) 514-7828;
FAX: (877) 591-2505 or (216) 591-2505;
8:00AM-8:00PM Eastern Time

The MPRSC focuses on patient and market access for MuGard Mucoadhesive. The staff ismade up of customer service representatives and oncology nurses who can provide patient insurance verification, specialty pharmacy procurement, product information, and, for qualified patients, co-pay and patient assistance. For additional information, please visit www.mugard.com.

Back to Top



AMGEN Assist
(888) 427-7478;
9:00AM-8:00PM Eastern Time
AMGEN Assist gives patients and healthcare professionals a single destination for access to eService and online forms, and makes it easier to find a program that would best meet each patient’s unique needs, including coverage and reimbursement services, co-pay support information, and assistance for uninsured patients. Please contact (888) 4ASSIST (888-427-7478)), or visit www.amgenassistonline.com.

Astellas Oncology
(888) 249-4918;
This hotline provides medical information and patient assistance.

Back to Top

AstraZeneca Cancer Support Network (AZCSN)
(866) 992-9276;
FAX (866) 279-0709;
8:00AM-6:00PM Eastern Time
AZCSN Patient Access Support for Arimidex, Casodex, Faslodex, and Zoladex screens for eligibility for a patient assistance program; verifies prescription drug coverage; identifies alternative coverage sources; and, assists with prior authorization procedures.

AstraZeneca Reimbursement Assistance is available at (877) 674-7140 for Faslodex and Zoladex. A team of reimbursement specialists is available to assist with information on coding, coverage, and payment.

Vandetaib Patient Access Support (VPAS) is assessed before the prescription is filled at Biologics at (800) 367-4999.

Back to Top

Bayer Healthcare Pharmaceuticals/Onyx Pharmaceuticals
(855) 6XOFIGO (696-3446);
FAX (855) 963-4463;
9:00AM-8:00PM Eastern Time
Patient assistance and general information is available for Xofigo.

Back to Top

Bristol-Myers Squibb Oncology
(800) 861-0048;
FAX (888) 776-2370;
8:00AM-8:00PM Eastern Time
(Reimbursement specialists available live Monday through Friday)
All Bristol-Myers Squibb Oncology products
Bristol-Myers Squibb Access/Support provides prior authorization assistance, appeals assistance, benefits investigation, general reimbursement guidance, and patient assistance.

Back to Top

Cardinal Health Specialty Solutions
Cardinal Health e-Recovery Program
(reimbursement solution tool);
(access to all Cardinal services)
Taking advantage of patient assistance and copay assistance programs is a full-time job. Our solutions are there to help save you time and money. Community practices like yours spend a significant amount of time every day helping patients find ways to offset the rising costs of cancer care. Accessing patient assistance programs (PAPs) for cancer and supportive care drugs is important, but takes so much time. Keeping up with all the changes in program requirements and forms, tracking applications and drug replacement are an incredible burden. Layered on top of that are all the emerging copay assistance programs. The Cardinal Health e-Recovery Program provides a web-based tool to make it all so much easier. Our team has the experience to help you make sure you don't miss any opportunities to help your patients access all the available programs out there.

Back to Top

Celgene Patient Support
(800) 931-8691;
5:00AM-4:00PM Pacific Time
Celgene Patient Support provides a dedicated, central point of contact for patients and healthcare professionals who use Celgene products. Celgene Patient Support is a free service that helps patients and healthcare professionals navigate the challenges of reimbursement, providing information about co-pay assistance, and answering questions about obtaining Celgene products.

Back to Top

Eisai Reimbursement Assistance and Access Program
(866) 613-4724;
FAX (866) 573-4724;
Fragmin FAX (866) 272-8805;
8:00AM-8:00PM Eastern Time
Aloxi, Halaven
The Eisai Reimbursement Assistance and Access Program currently provides patient assistance and reimbursement support for Aloxi and Halaven. A customer service representative will assist with Eisai product information, patient assistance programs for uninsured and ingident patients, underinsured patients, reimbursement questions, prior authorizations, insurance verifications, benefits investigations, referral to co-pay assistance programs, billing/coding questions, appeal assistance, and referral to disease-state assistance programs.

Back to Top

Foundation Medicine

Foundation Medicine Billing and Reimbursement Support
(888) 988-3639
Foundation Medicine provides payment plans that are available through our Patient Assistance Program and assistance may be available based on individual patient’s financial situation. Foundation Medicine is committed to making the billing and reimbursement process as straightforward as possible for patients. Contact our billing or client services team to learn more about the financial assistance program.

FoundationOne Careline
(866) 460-1928;
Monday-Thursday, 8:00AM-8:00PM Eastern Time;
Friday, 8:00AM-7:00PM Eastern Time
Foundation Medicine in collaboration with the Patient Advocate Foundation (PAF) is offering the FoundationOne Careline program to provide assistance to patients with cancer and their families seeking access to targeted therapies. The program offers personalized case management services to patients who are uninsured, underinsured or face other challenges that impact their access to care, and increases physicians’ ability to act on FoundationOne results

Genentech BioOncology
Genentech Access Solutions
(888) 249-4918;
Avastin, Erivedge, Gazyva, Herceptin, Kadcyla, Perjeta, Rituxan, Tarceva, Xeloda, Zelboraf
Genentech Access Solutions
provides one-stop access to a broad array of reimbursement information, and support and services for patients so that they can focus on treatment. In addition to providing information about co-pay assistance through independent public charities, Genentech Access Solutions can also help with common reimbursement challenges, insurance appeals and coverage denials, and referrals to the Genentech Access to Care Foundation.

Avastin Patient Assistance Program
(888) 249-4918;
FAX (888) 249-4919;
6:00AM-5:00PM Pacific Time
The Avastin Patient Assistance Program is designed to limit the overall annual cost of Avastin for eligible patients receiving treatment for FDA-approved indications. Participation in the Program provides a voluntary opportunity for physicians and eligible patients who reach an annual charge of 10,000mg to receive free Avastin from Genentech for the remainder of the 12-month period. The Program is open to all patients receiving Avastin (regardless of insurance coverage) with a household adjusted gross income of up to $100,000. Patients must be receiving Avastin for an FDA-approved indication.

(800) 443-6676;
8:30AM-5:00PM Eastern Time
Kytril, Roferon-A, Vesanoid, Xeloda
offers a range of reimbursement and literature search services, including third-party payer reimbursement information, coverage and benefits verification, billing codes and claims procedures, assistance with appeals, clinical literature searches, and enrollment information for Roche’s Medical Needs Program.

Back to Top

Genomic Health
Genomic Access Program (GAP)
(866) ONCOTYPE (662-6897);
Oncotype Dx
Genomic Health has established the Genomic Access Program (GAP) to provide financial and administrative support to patients ordering the Oncotype DX assay. The GAP program was established to assist qualified patients gain access to Oncotype DX and to help patients and physicians with the entire reimbursement process. GAP is made up of dedicated professionals who advocate on a patient’s behalf by working with physicians’ offices and insurance companies to facilitate access to Oncotype DX. In addition, GAP provides various comprehensive financial assistance programs for patients with financial hardship, uninsured patients, and underinsured patients based on eligibility. While GAP directly supports the patient, it also works with physicians’ offices to provide individualized assistance and support with every claim. GAP services are available at physician or patient request, do not require pre-registration, and can be accessed at any time before, during, or after you have ordered the Oncotype DX assay. Genomic Health is prepared to bill insurance plans directly on behalf of insured patients whose physician orders an Oncotype DX assay. Through GAP, the patient’s physician can request a Benefits Investigation to confirm whether the patient’s insurance plan is active and obtain available benefits information specific for Oncotype DX. Some insurers require a prior authorization before processing the patient’s specimen; the GAP team can also help facilitate this process. In the event that a payer denies an Oncotype DX claim, GAP representatives will identify the reasons and advocate on the patient’s behalf. For additional information, visit www.OncotypeDX.com.

(855) 4-Jakafi (855-452-5234);
FAX: (855) 525-7207;
6:00AM-5:00PM Pacific Time
is pleased to introduce Jakafi, the first and only JAK inhibitor for the treatment of intermediate or high-risk primary myelofibrosis, post-polycythemia vera myelofibrosis, and post-essential thrombocythemia myelofibrosis. Reimbursement services are offered through IncyteCares, and counselors are available to assist with prior authorization, reimbursement information, patient and copay assistance programs and education and support services for patients and healthcare practitioners.

Back to Top


Janssen Biotech
The Centocor Access One website provides reimbursement and patient support for Doxil, Procrit, and Zytiga.

(800) 609-1083;
FAX (800) 987-5572;
8:00AM-8:00PM Eastern Time
provides access to reimbursement information and support—patient assistance program to patients without insurance coverage (based on financial need); access to insurance guidelines for private, federal, and state plans; verification of insurance coverage; and, coding and billing assistance.

Procrit Line
(800) 553-3851;
FAX (800) 987-5572;
8:00AM-8:00PM Eastern Time
Leustatin, Procrit
provides easy access to reimbursement information and support—patient assistance program to patients without insurance coverage (based on financial need), coding and billing assistance, verification of insurance coverage, and assistance with appeals.

Zytiga One Support
(855) Zytiga (998-4421);
8:00AM-8:00PM Eastern Time
Zytiga One Support provides support services for Zytiga.

Lilly Oncology
Lilly PatientOne
(866) 4PatOne;
FAX (888) 242-6230
(Patient Assistance Applications);
FAX (877) 366-0585
(Reimburement Assistance Applications)
Alimta, Cyramza, Gemzar
Lilly Oncology’s PatientOne program provides reliable and individualized treatment support that addresses financial, access, and claim issues for patients who are candidates for Lilly’s oncology products. More information is available at www.lillypatientone.com/index.jsp.

Xtandi Access Services
(855) 8XTANDI (898-2634);
Xtandi Access Serivces offers an array of resources to help facilitate product coverage and payment, and to ensure that your patients can access Xtandi. Xtandi Access Services can: answer your questions about reimbursement, coverage, and payment for Xtandi; help you and your staff verify insurance requirements and track prior authorizations; provide assistance to you and your staff when prior authorizations are denied or when a patient’s insurer does not cover Xtandi; help you coordinate with a specialty pharmacy within our network that is contracted with your patient’s insurers to dispense Xtandi; determine whether your patients are eligible for patient or financial assistance for out-of-pocket costs associated with Xtandi; provide you with 24/7 access to status updates on your requests for patient assistance via our eService at www.astellasaccess.com; and, direct your patients to additional information about Xtandi treatment..

The Merck AccessProgram
(855) 257-3932;
8:00AM-8:00PM Eastern Time
The Merck Access Program can help answer questions about access and support, including insurance coverage for patients, reimbursement, benefit investigations, prior authorizations, appeals, and referrals to the Merck Patient Assistance Program.

Novartis Oncology
Oncology Access Now
Reimbursement Hotline
(800) 282-7630;
Patient Assistance Programs
(866) 884-5906
Novartis is committed to providing access to its medicines for those most in need. Through a variety of resources, including the Novartis Oncology Patient Assistance Program, the Novartis Oncology Reimbursement Hotline, and our support of independent Charitable Copay foundations, Novartis has made a firm commitment to enable patients in need to access medicines. Visit www.oncologyaccessnow.com for complete patient assistance, reimbursement, and clinical trial information.

Back to Top

Oncology Supply/ION
(888) 536-7697
OS/ION offers a unique value to pharmaceutical companies, service providers, and physician practices. Access provided by OS/ION empowers health care providers and industry companies to improve the efficiency, effectiveness, and quality of health care delivery to patients while enabling them to satisfy their respective missions. The collective portfolio of services and solutions from OS/ION include OS/ION Coding Workshops, monthly Web/teleconference workshops specifically for OS/ION members, which address pertinent topics such as basic coding rules and standards, and evaluation and management documentation requirements; OS/ION Medical Advisory Panel (MAP), comprising industry thought leaders with collective expertise in disease states, community-based practice, and business administration with an ongoing mission to deliver quality pharmaceutical products to patients as well as creative practice solutions to physicians; OS/ION Protocol Analyzer, a preloaded software program, complete with standard drug pricing from Oncology Supply and CMS’s most recent reimbursement data, which is available online at www.iononline.com, and calculates the overall cost of delivering chemotherapy in the practice; the OS/ION Pharmacy & Dispensing Program, with two distinct drug dispensing models that can be used to distribute medication for payment under the pharmacy benefits portion of a patient’s insurance and enables close analysis of each practice’s prescription-writing habits to determine which model is most suitable for use; OS/ION Practice Reimbursement Series, a series of reimbursement webinars that are designed to help network members stay abreast of breaking issues related to reimbursement and how it impacts them; OS/ION Vital Reimbursement Resources, a feature on the OS/ION Web site through which members are directed to an array of reimbursement material including CMS and Medicare enrollment forms, and timely news updates pertaining to reimbursement and legislation are posted in this section; and the overall OS/ION GPO Function, whereby the country’s largest diversified services organization for the community-based practitioner is designed to contract directly with pharmaceutical and biotech companies to support their products within the organization’s membership.

Back to Top

Onyx Pharmaceuticals
Onyx 360
(855) ONYX-360 (669-9360);
6:00AM-5:00PM Pacific Time
Reimbursement and payment support (help obtaining assistance in paying for your medication, assistance with co-pays and co-insurance, help verifying insurance benefits); treatment support (information about your disease, understanding side effects); and, day-to-day and emotional support (assistance and transportation to scheduled appointments, patient and caregiver counseling services, support group information). Onyx 360 is a comprehensive patient and caregiver support and services program designed to help patients navigate the treatment journey, including reimbursement and payment support, treatment support, and referrals to third-party organizations for day-to-day and emotional support. Dedicated oncology nurse advocates are available Monday through Friday from 9:00AM to 8:00PM Eastern Time at (855) 669-9360 to assist patients, caregivers, and healthcare providers.

Reach for Nexavar
(866) NEXAVAR (639-2827);
9:00AM-8:00PM Eastern Time
Onyx is committed to helping patients gain access to Nexavar. The Resources for Expert Assistance and Care Helpline (REACH) is avaliable to answer questions about Nexavar treatment, reimbursement, and patient support.

Back to Top

Pfizer Oncology
Pfizer RxPathways
(877) 744-5675;
FAX (800) 708-3430;
9:00AM-8:00PM Eastern Time
Aromasin, Bosulif, Camptosar, Ellence, Emcyt, Idamycin, Inlyta, Neumega, Sutent, Torisel, Xalkori, Zinecard
When patients have difficulty getting access to their Pfizer medicines, Pfizer RxPathways (which has replaced Pfizer First Resource) may provide the support services that can help. Services available to eligible patients include free medicines, referral to co-pay help, reimbursement support services, appeals process information, and specialty pharmacy referral.

Sutent Patient Call Center
(877) 5SUTENT;
8:00AM-7:00PM Central Time
The Sutent Patient Call Center is staffed by trained oncology certified nurse consultants who can give general information about Sutent treatment and potential side effects.

Back to Top

YOU&i Support Program
(877) 877-3536;
YOU&i Support Program is a personalized support program from Pharmacyclics and Janssen Biotech that includes information on access and affordability, nurse call support, and resources for patients being treated with Imbruvica. Patients or their provider may access the YOU&I Support Program by visiting www.youandiaccess.com or www.imbruvica.com or calling (877) 877-3536. YOU&i Support Program provides rapid (within 2 business days) benefit investigation, information about the prior authorization process, information about the insurance appeals process and can refer you to a specialty pharmacy. Patients may qualify for YOU&i Start: (If a patient is experiencing an insurance coverage decision delay, this program may give you access to Imbruvica.) Patients may also qualify for YOU&i Instant Savings Program: (If a patient has commercial health insurance and meets eligibility requirements, they will pay no more than $10 per month for Imbruvica.).

Sanofi Oncology
Sanofi Patient Connection
(888) visitSPC (847-4877);
FAX (888) 847-1797;
9:00AM-8:00PM Eastern Time
As part of Sanofi's commitment to comprehensive disease management we offer resources to help healthcare professionals provide care for their patients. Sanofi Patient Connection is a program that includes patient assistance and reimbursement services to help take the challenge out of gaining access to Sanofi products for patients in need. Visit the Sanofi Patient Connection website for additional information or call (888) visitSPC.

Back to Top

Seattle Genetics
SeaGen Secure
(855) 4SEAGEN (855-473-2436, Option 1);
FAX: (855) 557-2480;
9:00AM-8:00PM Eastern Time
SeaGen Secure is a comprehensive reimbursement support hotline and patient assistance program for Adcetris. Reimbursement counselors are available to provide coverage, coding and reimbursement information in addition to case management for our patient assistance programs. Patient assistance is available to uninsured and underinsured patients that have been prescribed Adcetris. Eligibility for patient assistance is based on gross family household income, residency and diagnosis. Additional program services include benefit investigations, assistance with underpaid/denied claims, Adcetris policy information and alternate funding research.

Back to Top

Takeda Oncology
Velcade Reimbursement Assistance Program (VRAP)
(866) VELCADE, Option #2;
5:00AM-5:00PM Pacific Time
Takeda Oncology
has developed this reimbursement resource website as a tool to help physicians understand the healthcare insurance environment for Velcade. While payers generally reimburse for Velcade, it is the details that dictate coverage for each individual patient’s healthcare. This website provides general guidance regarding steps to support appropriate reimbursement and patient access to Velcade treatment. The VRAP line can also assist with benefit investigation and transportation assistance.

Back to To

Teva Oncology
CORE (Comprehensive Oncology Reimbursement Expertise)
(888) 587-3263;
FAX (866) 676-4073;
9:00AM-8:00PM Eastern Time
CORE provides support for branded Teva Oncology products. Teva Oncology support programs are designed to help patients and healthcare providers navigate the reimbursement landscape with resources aimed at clarifying issues and assisting with the claims process. Specific assistance includes benefit verification and coverage determination, policy benefits and limitations, personalized support through the claims process, and appeals support.